Latest Breaking News On - Novartis gene - Page 1 : comparemela.com

REGENXBIO Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD

A single ABBV-RGX-314 gene therapy treatment has the potential to become a new standard-of-care option among anti-VEGF treatments by sustaining vision health.

United statesDana cormackJeffreys heierChris brinzeyExchange commissionDrug administrationEuropean medicines agencyRetina research at ophthalmic consultants of bostonClearside biomedical incCorporate communicationsVitreoretinal serviceSecurities exchangeChief executive officerRetina researchOphthalmic consultantsClearside biomedical

First-ever Israeli win in Advanced Therapies Award event

First-ever Israeli win in Advanced Therapies Award event
israel21c.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israel21c.org Daily Mail and Mail on Sunday newspapers.

United statesShai meretzkyRocket pharmaceuticalsBonus biogroupAdvanced therapies awardCell therapy biotech innovationAdvanced therapies weekAdvanced therapies awardsNovartis gene

UK at an inflection point for newborn screening for spinal muscular atrophy

UK at an inflection point for newborn screening for spinal muscular atrophy
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

United kingdomCzech republicGiles lomaxRobert guthrieNational institute for healthUnited kingdom national screening committeeNewborn screening allianceUnited kingdom wideNewborn screeningSpinal muscular atrophySpinal muscular atrophy treatmentPatients identifiedSystematic reviewNational instituteCare excellenceScreening alliance

JAG, STARS Acquire North Carolina Community

The buyers plan to complete unit renovations begun by the prior owners. Jefferson Apartment Group and STARS REI have acquired a project in North Carolina.

Research triangle parkNorth carolinaUnited statesOptimist parkJames butzFelipe lattapiatJefferson apartment groupJefferson apartmentApartment groupSpyglass capitalMeadow laneResearch triangleNovartis geneTar heelFort washington

What happens when a $2 million gene therapy is not enough

(This Aug. 12 story has been corrected to state that ICER's final analysis was that Zolgensma was cost effective at a price of $1.1 million to $1.9

United statesDeena beasleyRoger hajjarElizabeth kutschkeRoche evrysdiSitra tauscher wisniewskiAmanda cookEric coxSree chaguturuSara ledwithVasant narasimhanMaha radhakrishnanSteven pearsonStacie dusetzinaBen kutschkeCaroline humer